Literature DB >> 18068688

Expression of cytochrome P450 2A5 in a glucose-6-phosphate dehydrogenase-deficient mouse model of oxidative stress.

Kathleen D Nichols1, Gordon M Kirby.   

Abstract

Murine hepatic cytochrome P450 2A5 (CYP2A5), unlike most CYP enzymes, is upregulated during hepatitis and hepatotoxic conditions, but the common stimulus for its induction remains unknown. We investigated the involvement of oxidative stress in the regulation of CYP2A5 expression using an oxidative stress-sensitive glucose-6-phosphate dehydrogenase (G6PD)-deficient mouse model. Treatment of deficient and wild-type mice with the prototypical CYP2A5-inducer pyrazole for 72h led to a significantly greater degree of induction of CYP2A5 mRNA, protein and activity in deficient mice, with the greatest increase observed in animals homozygous for the deficiency. However, markers of oxidative stress including protein carbonyl, 8-hydroxydeoxyguanosine, malondiadehyde and 4-hydroxyalkenal levels were unaltered with pyrazole treatment. Furthermore, CYP2A5 expression was not altered in G6PD-deficient mice treated with the pro-oxidant menadione whereas DNA, lipid, and protein markers of oxidative stress were significantly increased. The antioxidant polyethylene glycol-conjugated catalase, while decreasing oxidative stress in menadione-treated mice, did not prevent the induction of CYP2A5 by pyrazole. Finally, the ER stress marker protein, GRP78, was increased following pyrazole treatment in G6PD-deficient compared to wild-type mice. These findings do not support a central role for generalized cellular oxidative stress in the regulation of CYP2A5 and suggest that additional factors related to G6PD-deficiency, such as ER stress, may be involved.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18068688     DOI: 10.1016/j.bcp.2007.10.032

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

Review 1.  Cytochrome P450 regulation: the interplay between its heme and apoprotein moieties in synthesis, assembly, repair, and disposal.

Authors:  Maria Almira Correia; Peter R Sinclair; Francesco De Matteis
Journal:  Drug Metab Rev       Date:  2010-09-23       Impact factor: 4.518

Review 2.  Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease.

Authors:  Peter A Hecker; Jane A Leopold; Sachin A Gupte; Fabio A Recchia; William C Stanley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-15       Impact factor: 4.733

3.  Up- and down-modulation of liver cytochrome P450 activities and associated events in two murine malaria models.

Authors:  Ana Cecilia A X De-Oliveira; Renato S Carvalho; Flavio H M Paixão; Hellen S Tavares; Luciana S Gueiros; Carolina M Siqueira; Francisco J R Paumgartten
Journal:  Malar J       Date:  2010-03-22       Impact factor: 2.979

4.  Discernment of possible mechanisms of hepatotoxicity via biological processes over-represented by co-expressed genes.

Authors:  Jeff W Chou; Pierre R Bushel
Journal:  BMC Genomics       Date:  2009-06-18       Impact factor: 3.969

5.  Pyrazole induced oxidative liver injury independent of CYP2E1/2A5 induction due to Nrf2 deficiency.

Authors:  Yongke Lu; Pengfei Gong; Arthur I Cederbaum
Journal:  Toxicology       Date:  2008-08-03       Impact factor: 4.221

6.  Modulation of cytochrome P450 2A5 activity by lipopolysaccharide: low-dose effects and non-monotonic dose-response relationship.

Authors:  Ana C A X De-Oliveira; Kátia S Poça; Paulo R R Totino; Francisco J R Paumgartten
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

7.  DNA damage and synaptic and behavioural disorders in glucose-6-phosphate dehydrogenase-deficient mice.

Authors:  Margaret M Loniewska; Anmol Gupta; Shama Bhatia; Isabel MacKay-Clackett; Zhengping Jia; Peter G Wells
Journal:  Redox Biol       Date:  2019-09-18       Impact factor: 11.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.